Percutaneous Radiofrequency ablation for Pulmonary Metastasis from Colorectal Cancer: Phase II Clinical Trial
- Conditions
- Pulmonary metastasis from colorectal cancer
- Registration Number
- JPRN-UMIN000014391
- Lead Sponsor
- Department of Radiology, Okayama University Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Not provided
1)Lack of safe needle insertion path. 2)RFA is considered to be de hazardous because of critical organs close to the target lesion. 3)Presence of sever comorbidities. 4)Presence of uncontrolled other malignant diseases. 5)Presence of peritoneal dissemination and/or malignant ascites. 6)Fever higher than 38-Celsius degree. 7)Severe impairment of contralateral pulmonary function. 8)Presence of pulmonary hypertension. 9)Presence of interstitial pneumonia. 10)Usage of anticoagulants and antiplatelet agents. 11)Pregnant patients. 12)Patients who are considered to be unsuitable for inclusion by physicians due to other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method